<div class="pb-8 content gradient-lighter"><div class="content-header"><div class="container"><button id="button-back"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg width="15" height="15" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M6.85355 3.14645C7.04882 3.34171 7.04882 3.65829 6.85355 3.85355L3.70711 7H12.5C12.7761 7 13 7.22386 13 7.5C13 7.77614 12.7761 8 12.5 8H3.70711L6.85355 11.1464C7.04882 11.3417 7.04882 11.6583 6.85355 11.8536C6.65829 12.0488 6.34171 12.0488 6.14645 11.8536L2.14645 7.85355C1.95118 7.65829 1.95118 7.34171 2.14645 7.14645L6.14645 3.14645C6.34171 2.95118 6.65829 2.95118 6.85355 3.14645Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path></svg></div></div></button><div class="title">Comorbidities</div></div><div class="subtitle"></div></div><div class="pt-2 presentation_wrapper"><h2>Comborbidities associated with PTSD</h2><div class="panel"><p><span class="text-bold">Filter</span> the graph by medical or psychiatric comorbidities. <span class="text-bold">Select</span> a comorbidity bar to see more info.</p></div><div id="ptsd-comorbidities-bar-chart" class="round-lg" data-full-bleed="true"></div><div data-full-bleed="true" class="round-lg grid grid-cols-1 p-4 bg-black-900 items-start justify-between bg-[#d4e4ee] rounded-lg mt-2 mx-2"><h3>Medical Comorbidities</h3><div class="relative flex flex-col items-center justify-center flex-1 w-full"><bar-chart bardata="[{&quot;id&quot;:&quot;0d39782b-a212-404c-a808-df32e8fb8edd&quot;,&quot;groupId&quot;:0,&quot;label&quot;:&quot;Substance use&quot;,&quot;start&quot;:46.0,&quot;end&quot;:null,&quot;fill&quot;:&quot;#33ff57&quot;},{&quot;id&quot;:&quot;6f36f476-7f3e-4535-b5ca-3e5334b050cc&quot;,&quot;groupId&quot;:0,&quot;label&quot;:&quot;Alcohol use&quot;,&quot;start&quot;:46.0,&quot;end&quot;:null,&quot;fill&quot;:&quot;#ff8d33&quot;},{&quot;id&quot;:&quot;60071b29-5b67-4689-9b5e-642a0ada7588&quot;,&quot;groupId&quot;:0,&quot;label&quot;:&quot;Major Depressive Disorder&quot;,&quot;start&quot;:50.0,&quot;end&quot;:null,&quot;fill&quot;:&quot;#33ff8d&quot;},{&quot;id&quot;:&quot;18bf0c17-aab4-416d-ac97-23a1199e5445&quot;,&quot;groupId&quot;:0,&quot;label&quot;:&quot;Anxiety&quot;,&quot;start&quot;:10.0,&quot;end&quot;:null,&quot;fill&quot;:&quot;#ffc733&quot;},{&quot;id&quot;:&quot;7b95d780-7f91-4822-bfde-63ddb12c17a7&quot;,&quot;groupId&quot;:0,&quot;label&quot;:&quot;Self-harm&quot;,&quot;start&quot;:5.0,&quot;end&quot;:19.0,&quot;fill&quot;:&quot;#ff5733&quot;},{&quot;id&quot;:&quot;21be3c0c-539e-4f3b-a536-088ccc728de1&quot;,&quot;groupId&quot;:1,&quot;label&quot;:&quot;Sleep dysfunction&quot;,&quot;start&quot;:70.0,&quot;end&quot;:87.0,&quot;fill&quot;:&quot;#338dff&quot;},{&quot;id&quot;:&quot;4a9c86e0-ade5-42c0-aaa3-f5fae14593de&quot;,&quot;groupId&quot;:1,&quot;label&quot;:&quot;Chronic Pain&quot;,&quot;start&quot;:20.0,&quot;end&quot;:null,&quot;fill&quot;:&quot;#e5ff33&quot;},{&quot;id&quot;:&quot;624e995e-280a-4030-ac93-71d6b39ac8be&quot;,&quot;groupId&quot;:1,&quot;label&quot;:&quot;Cardiometabolic disorders&quot;,&quot;start&quot;:25.0,&quot;end&quot;:null,&quot;fill&quot;:&quot;#e5ff33&quot;},{&quot;id&quot;:&quot;a59cb7b8-50a8-4b3e-ba45-c48b4f627750&quot;,&quot;groupId&quot;:1,&quot;label&quot;:&quot;Dementia&quot;,&quot;start&quot;:4.7,&quot;end&quot;:7.8,&quot;fill&quot;:&quot;#e5ff33&quot;}]" margin="{&quot;top&quot;:40.0,&quot;bottom&quot;:20.0,&quot;left&quot;:200.0,&quot;right&quot;:40.0}" aspect-ratio="2"><section slot="panel" id="0d39782b-a212-404c-a808-df32e8fb8edd"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">46%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#33ff57]">Substance use</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#33ff57]"><h3>Substance use</h3><p>The self-medication theory is the leading explanation for the connection between substance use and PTSD. According to this theory, individuals with PTSD are more likely to turn to alcohol or drugs to cope with the distressing symptoms and consequences of their condition, increasing their risk of substance use<a aria-describedby="ref-marker">13</a>. Substance use is more common among men than women<a aria-describedby="ref-marker">14</a>. Veterans with PTSD have an increased risk of substance use disorders<a aria-describedby="ref-marker">15</a>. </p></div></div></div></section><div slot="icon" id="0d39782b-a212-404c-a808-df32e8fb8edd"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="6f36f476-7f3e-4535-b5ca-3e5334b050cc"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">10%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#ff8d33]">Alcohol use</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#ff8d33]"><h3>Alcohol use</h3><p>The self-medication theory is the leading explanation for the connection between substance use and PTSD. According to this theory, individuals with PTSD are more likely to turn to alcohol or drugs to cope with the distressing symptoms and consequences of their condition, increasing their risk of substance use<a aria-describedby="ref-marker">13</a>. Research indicates a reciprocal relationship between PTSD and alcohol use: PTSD may lead to alcohol use due to self-medication, while alcohol use may increase vulnerability to traumatic events and subsequent PTSD<a aria-describedby="ref-marker">13</a>. </p></div></div></div></section><div slot="icon" id="6f36f476-7f3e-4535-b5ca-3e5334b050cc"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="60071b29-5b67-4689-9b5e-642a0ada7588"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">50%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#33ff8d]">Major Depressive Disorder (MDD)</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#33ff8d]"><h3>Major Depressive Disorder</h3><p>Approximately 50% of individuals with PTSD are reported to have MDD<a aria-describedby="ref-marker">3</a><a aria-describedby="ref-marker">9</a>. Furthermore, comorbidity suggests an increased illness burden with a severe course of impairments and delay in treatment response. It is thought that depression may increase the risk of developing PTSD following a traumatic experience<a aria-describedby="ref-marker">17</a>.</p></div></div></div></section><div slot="icon" id="60071b29-5b67-4689-9b5e-642a0ada7588"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="18bf0c17-aab4-416d-ac97-23a1199e5445"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">10%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#ffc733]">Anxiety</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#ffc733]"><h3>Anxiety</h3><p>Individuals with PTSD are more likely to have an anxiety disorder, with odds ranging from 2.4 to 7.1 times higher<a aria-describedby="ref-marker">9</a>. Anxiety is often triggered by reminders of the traumatic event and can result in pervasive feelings of worry and apprehension<a aria-describedby="ref-marker">2</a>. The most prevalent among these anxiety disorders include phobias such as simple, social, and agoraphobia, as well as generalized anxiety disorder<a aria-describedby="ref-marker">2</a><a aria-describedby="ref-marker">9</a>. Research also indicates that individuals with PTSD may be at a higher risk of developing OCD. Experiences of trauma and violation may lead to heightened sensitivity to perceived mental contamination and a feeling of 'dirtiness’ that may contribute to the development or exacerbation of OCD symptoms<a aria-describedby="ref-marker">18</a>. </p></div></div></div></section><div slot="icon" id="18bf0c17-aab4-416d-ac97-23a1199e5445"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="7b95d780-7f91-4822-bfde-63ddb12c17a7"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">5-19%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#ff5733]">Self-harm</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#ff5733]"><h3>Self-harm</h3><p>Symptoms of PTSD have been identified as predictors of deliberate self-harm (DSH)<a aria-describedby="ref-marker">4</a>. Depression in patients with PTSD often co-exists with suicidal ideation<a aria-describedby="ref-marker">2</a>. Patients with substance use disorders (SUD) are of special interest, often showing elevated rates of suicide attempts and DSH<a aria-describedby="ref-marker">4</a>. </p></div></div></div></section><div slot="icon" id="7b95d780-7f91-4822-bfde-63ddb12c17a7"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="21be3c0c-539e-4f3b-a536-088ccc728de1"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">5-19%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#338dff]">Sleep dysfunction</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#338dff]"><h3>Sleep dysfunction</h3><p>70-87% of patients diagnosed with PTSD experience sleep disturbances, including insomnia, posttraumatic nightmares, awakenings, periodic limb movement disorder (PLMD), and obstructive sleep apnea (OSA)<a aria-describedby="ref-marker">8</a><a aria-describedby="ref-marker">19</a><a aria-describedby="ref-marker">20</a>. Posttraumatic nightmares often involve reliving the trauma and can lead to intense fear or anxiety upon waking, making it difficult to return to sleep<a aria-describedby="ref-marker">21</a>.Awakenings in PTSD may not always be linked to distressing dreams. About 33% of PTSD patients also suffer from PLMD, which can cause awakenings<a aria-describedby="ref-marker">21</a>. Insomnia symptoms are reported by approximately 70% of patients and are often related to increased autonomic arousal and fear of sleep, including fear of losing control or experiencing nightmares<a aria-describedby="ref-marker">20</a>. OSA is also common among PTSD patients, affecting 40-90% of patients<a aria-describedby="ref-marker">20</a>.</p></div></div></div></section><div slot="icon" id="21be3c0c-539e-4f3b-a536-088ccc728de1"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="4a9c86e0-ade5-42c0-aaa3-f5fae14593de"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">5-19%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#e5ff33]">Chronic pain</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#e5ff33]"><h3>Chronic pain</h3><p>PTSD and chronic pain co-occur through various mechanisms. In PTSD, catastrophizing, characterized by magnifying pain or trauma severity, feeling overwhelmed, and expecting the worst outcome, amplifies trauma perception and emotional distress. Individuals experiencing this may exhibit less control over their pain and a greater emotional impact<a aria-describedby="ref-marker">22</a>. Additionally, dysregulated cortisol levels may increase sensitivity to pain<a aria-describedby="ref-marker">23</a>. Individuals experiencing both chronic pain and posttraumatic stress disorder (PTSD) tend to suffer from more intense pain and reduced quality of life compared to those solely dealing with chronic pain. Both conditions are closely linked, with high occurrences of chronic pain in PTSD patients and vice versa. Moreover, individuals with this dual diagnosis are commonly prescribed opioid medications for pain relief, putting them at a higher risk for opioid use<a aria-describedby="ref-marker">24</a>.</p></div></div></div></section><div slot="icon" id="4a9c86e0-ade5-42c0-aaa3-f5fae14593de"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="624e995e-280a-4030-ac93-71d6b39ac8be"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">25%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#e5ff33]">Cardiometabolic disorders</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#e5ff33]"><h3>Cardiometabolic disorders</h3><p>Research indicated that PTSD is associated with increased rates of physical comorbidities involving immune dysregulation, such as metabolic syndromes, obesity, diabetes, hypertension, hyperlipidemia, atherosclerotic cardiovascular disease, and autoimmune diseases<a aria-describedby="ref-marker">25</a><a aria-describedby="ref-marker">26</a>.Studies show that female survivors of the 9/11 attacks with PTSD faced a higher risk of heart disease hospitalization<a aria-describedby="ref-marker">26</a>.</p></div></div></div></section><div slot="icon" id="624e995e-280a-4030-ac93-71d6b39ac8be"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div><section slot="panel" id="a59cb7b8-50a8-4b3e-ba45-c48b4f627750"><div class="flex flex-col gap-4 rounded-lg bg-[#e6f0f6] p-8"><div class="flex flex-row items-center justify-start"><div class="w-12 text-black"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg preserveAspectRatio="xMidYMid meet" width="100%" height="100%" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg">
    <path d="M11.5 1C11.7761 1 12 1.22386 12 1.5V13.5C12 13.7761 11.7761 14 11.5 14C11.2239 14 11 13.7761 11 13.5V1.5C11 1.22386 11.2239 1 11.5 1ZM9.5 3C9.77614 3 10 3.22386 10 3.5V13.5C10 13.7761 9.77614 14 9.5 14C9.22386 14 9 13.7761 9 13.5V3.5C9 3.22386 9.22386 3 9.5 3ZM13.5 3C13.7761 3 14 3.22386 14 3.5V13.5C14 13.7761 13.7761 14 13.5 14C13.2239 14 13 13.7761 13 13.5V3.5C13 3.22386 13.2239 3 13.5 3ZM5.5 4C5.77614 4 6 4.22386 6 4.5V13.5C6 13.7761 5.77614 14 5.5 14C5.22386 14 5 13.7761 5 13.5V4.5C5 4.22386 5.22386 4 5.5 4ZM1.5 5C1.77614 5 2 5.22386 2 5.5V13.5C2 13.7761 1.77614 14 1.5 14C1.22386 14 1 13.7761 1 13.5V5.5C1 5.22386 1.22386 5 1.5 5ZM7.5 5C7.77614 5 8 5.22386 8 5.5V13.5C8 13.7761 7.77614 14 7.5 14C7.22386 14 7 13.7761 7 13.5V5.5C7 5.22386 7.22386 5 7.5 5ZM3.5 7C3.77614 7 4 7.22386 4 7.5V13.5C4 13.7761 3.77614 14 3.5 14C3.22386 14 3 13.7761 3 13.5V7.5C3 7.22386 3.22386 7 3.5 7Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path>
</svg></div></div></div><span class="px-1 text-3xl">4.7 - 7.8%</span></div><div class="mt-4"><p>of patients with PTSD had <span class="bg-[#e5ff33]">Dementia</span> as a comorbidity</p></div><div class="flex flex-col items-center justify-center col-span-1"><div class="pl-2 border-l-4 border-[#e5ff33]"><h3>Dementia</h3><p>Individuals with PTSD face a 1.55x higher risk of developing dementia<a aria-describedby="ref-marker">12</a>. The exact mechanisms linking PTSD to cognitive decline and dementia remain unclear<a aria-describedby="ref-marker">28</a>. However, research suggests that intrusive thoughts, a key symptom of PTSD, may predict cognitive impairment years later<a aria-describedby="ref-marker">28</a>. </p></div></div></div></section><div slot="icon" id="a59cb7b8-50a8-4b3e-ba45-c48b4f627750"><?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_13" data-name="Layer 13" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 137.98 141.69">
  <g>
    <circle cx="72.3" cy="71.27" r="55.41" style="fill: #fff; stroke: #005178; stroke-miterlimit: 10; stroke-width: 6px;"/>
    <circle cx="72.3" cy="71.27" r="48.69" style="fill: #5a97cb; stroke-width: 0px;"/>
  </g>
  <path d="m82.04,99.49c0-1,.14-2.02-.03-2.99-.5-2.91.75-3.73,3.52-3.54,4.2.29,8.19-.29,9.92-4.96.45-1.22.55-2.65.51-3.97-.13-4.15-.78-8.3,4.98-9.61,1.56-.35,3.04-2.23,1.07-4.38-1.04-1.14-1.81-2.57-2.51-3.96-1.59-3.21-3.61-6.15-4.08-9.95-2.04-16.69-22.36-24.86-37.8-16.95-15.54,7.97-19.07,27.28-8.02,39.9,5.02,5.74,7.59,12.56,6.53,20.39" style="fill: none; stroke: #fff; stroke-miterlimit: 10; stroke-width: 2px;"/>
  <text transform="translate(64.3 60.7)" style="fill: #fff; font-family: Calibri-Bold, Calibri; font-size: 15.53px; font-weight: 700;"><tspan x="0" y="0">?</tspan></text>
  <path d="m82.62,51.98c-.25-.57-.62-1.09-1.11-1.54-1.8-1.64-4.54-1.61-6.3.02-.65-.54-1.4-.97-2.22-1.24-.9-2.71-3.46-4.66-6.47-4.66-3.77,0-6.82,3.05-6.82,6.82-3.77,0-6.82,3.05-6.82,6.82s3.05,6.82,6.82,6.82c1.74,0,3.32-.65,4.52-1.72.83,1.52,2.47,2.52,4.31,2.44,1.94-.09,3.55-1.36,4.18-3.08.78.79,1.88,1.26,3.07,1.2,1.22-.06,2.28-.64,2.99-1.52.49.11,1,.17,1.53.14,3.08-.14,5.45-2.75,5.31-5.83-.09-2.05-1.28-3.78-2.98-4.67Z" style="fill: none; stroke: #fff; stroke-miterlimit: 10;"/>
</svg></div></bar-chart></div></div><div class="references panel"><h4 class="uppercase">References </h4><div class="pl-3"><div class="flex flex-col w-full gap-2 mt-2"><ol class="list">
    <li>
        <p>McCauley JL, Killeen T, Gros DF, Brady KT, Back SE. Posttraumatic Stress Disorder
            and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment. <em>Clin Psychol (New
                York)</em>. 2012;19(3):10.1111/cpsp.12006. doi:10.1111/cpsp.12006</p>
    </li>
    <li>
        <p>Qassem T, Aly-ElGabry D, Alzarouni A, Abdel-Aziz K, Arnone D. Psychiatric
            Co-Morbidities in Post-Traumatic Stress Disorder: Detailed Findings from the Adult Psychiatric Morbidity
            Survey in the English Population. <em>Psychiatr Q</em>. 2021;92(1):321-330. doi:10.1007/s11126-020-09797-4
        </p>
    </li>
    <li>
        <p>Rytwinski NK, Scur MD, Feeny NC, Youngstrom EA. The co-occurrence of major
            depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. <em>J Trauma
                Stress</em>. 2013;26(3):299-309. doi:10.1002/jts.21814</p>
    </li>
    <li>
        <p>Brady KT, Killeen TK, Brewerton T, Lucerini S. Comorbidity of psychiatric disorders
            and posttraumatic stress disorder. <em>J Clin Psychiatry</em>. 2000;61 Suppl 7:22-32.</p>
    </li>
    <li>
        <p>Dixon-Gordon KL, Tull MT, Gratz KL. Self-injurious behaviors in posttraumatic
            stress disorder: an examination of potential moderators. <em>J Affect Disord</em>. 2014;166:359-367.
            doi:10.1016/j.jad.2014.05.033</p>
    </li>
    <li>
        <p>Tesarz J, Baumeister D, Andersen TE, Vaegter HB. Pain perception and processing in
            individuals with posttraumatic stress disorder: a systematic review with meta-analysis. <em>Pain Rep</em>.
            2020;5(5):e849. Published 2020 Sep 17. doi:10.1097/PR9.0000000000000849</p>
    </li>
    <li>
        <p>Neigh GN, Ali FF. Co-morbidity of PTSD and immune system dysfunction: opportunities
            for treatment. <em>Curr Opin Pharmacol</em>. 2016;29:104-110. doi:10.1016/j.coph.2016.07.011</p>
    </li>
    <li>
        <p>Edmondson D, von Känel R. Post-traumatic stress disorder and cardiovascular
            disease. <em>Lancet Psychiatry</em>. 2017;4(4):320-329. doi:10.1016/S2215-0366(16)30377-7</p>
    </li>
    <li>
        <p>Günak MM, Billings J, Carratu E, Marchant NL, Favarato G, Orgeta V. Post-traumatic
            stress disorder as a risk factor for dementia: systematic review and meta-analysis [published correction
            appears in Br J Psychiatry. 2021 Mar;218(3):174]. <em>Br J Psychiatry</em>. 2020;217(5):600-608.
            doi:10.1192/bjp.2020.150</p>
    </li>
    <li>
        <p>Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic
            stress disorder: epidemiology, impact and approaches to management. <em>CNS Drugs</em>. 2006;20(7):567-590.
            doi:10.2165/00023210-200620070-00003</p>
    </li>
    <li>
        <p>Flanagan JC, Korte KJ, Killeen TK, Back SE. Concurrent Treatment of Substance Use
            and PTSD. <em>Curr Psychiatry Rep</em>. 2016;18(8):70. doi:10.1007/s11920-016-0709-y</p>
    </li>
    <li>
        <p>Leeies M, Pagura J, Sareen J, Bolton JM. The use of alcohol and drugs to
            self-medicate symptoms of posttraumatic stress disorder. <em>Depress Anxiety</em>. 2010;27(8):731-736.
            doi:10.1002/da.20677</p>
    </li>
    <li>
        <p>Wisco BE, Marx BP, Wolf EJ, Miller MW, Southwick SM, Pietrzak RH. Posttraumatic
            stress disorder in the US veteran population: results from the National Health and Resilience in Veterans
            Study. <em>J Clin Psychiatry</em>. 2014;75(12):1338-1346. doi:10.4088/JCP.14m09328</p>
    </li>
    <li>
        <p>Smith NDL, Cottler LB. The Epidemiology of Post-Traumatic Stress Disorder and
            Alcohol Use Disorder. <em>Alcohol Res</em>. 2018;39(2):113-120.</p>
    </li>
    <li>
        <p>Angelakis S, Nixon RDV. The Comorbidity of PTSD and MDD: Implications for Clinical
            Practice and Future Research. <em>Behaviour Change</em>. 2015;32(1):1-25. doi:10.1017/bec.2014.26</p>
    </li>
    <li>
        <p>Wadsworth LP, Van Kirk N, August M, et al. Understanding the overlap between OCD
            and trauma: development of the OCD trauma timeline interview (OTTI) for clinical settings. <em>Curr
                Psychol</em>. 2023;42(9):6937-6947. doi:10.1007/s12144-021-02118-3</p>
    </li>
    <li>
        <p>Leskin GA, Woodward SH, Young HE, Sheikh JI. Effects of comorbid diagnoses on sleep
            disturbance in PTSD. <em>J Psychiatr Res</em>. 2002;36(6):449-452. doi:10.1016/s0022-3956(02)00025-0</p>
    </li>
    <li>
        <p>Lancel M, van Marle HJF, Van Veen MM, van Schagen AM. Disturbed Sleep in PTSD:
            Thinking Beyond Nightmares. <em>Front Psychiatry</em>. 2021;12:767760. Published 2021 Nov 24.
            doi:10.3389/fpsyt.2021.767760</p>
    </li>
    <li>
        <p>El-Solh AA. Management of nightmares in patients with posttraumatic stress
            disorder: current perspectives. <em>Nat Sci Sleep</em>. 2018;10:409-420. Published 2018 Nov 26.
            doi:10.2147/NSS.S166089</p>
    </li>
    <li>
        <p>Kind S, Otis JD. The Interaction Between Chronic Pain and PTSD. <em>Curr Pain
                Headache Rep</em>. 2019;23(12):91. Published 2019 Nov 28. doi:10.1007/s11916-019-0828-3</p>
    </li>
    <li>
        <p>Hannibal KE, Bishop MD. Chronic stress, cortisol dysfunction, and pain: a
            psychoneuroendocrine rationale for stress management in pain rehabilitation. <em>Phys Ther</em>.
            2014;94(12):1816-1825. doi:10.2522/ptj.20130597</p>
    </li>
    <li>
        <p>Morasco BJ, Lovejoy TI, Lu M, Turk DC, Lewis L, Dobscha SK. The relationship
            between PTSD and chronic pain: mediating role of coping strategies and depression. <em>Pain</em>.
            2013;154(4):609-616. doi:10.1016/j.pain.2013.01.001</p>
    </li>
    <li>
        <p>Hori H, Kim Y. Inflammation and post-traumatic stress disorder. <em>Psychiatry Clin
                Neurosci</em>. 2019;73(4):143-153. doi:10.1111/pcn.12820</p>
    </li>
    <li>
        <p>Coughlin SS. Post-traumatic Stress Disorder and Cardiovascular Disease. <em>Open
                Cardiovasc Med J</em>. 2011;5:164-170. doi:10.2174/1874192401105010164</p>
    </li>
    <li>
        <p>Jordan HT, Stellman SD, Morabia A, et al. Cardiovascular disease hospitalizations
            in relation to exposure to the September 11, 2001 World Trade Center disaster and posttraumatic stress
            disorder. <em>J Am Heart Assoc</em>. 2013;2(5):e000431. Published 2013 Oct 24. doi:10.1161/JAHA.113.000431
        </p>
    </li>
    <li>
        <p>Lawrence KA, Pachner TM, Long MM, Henderson S, Schuman DL, Plassman BL. Risk and
            protective factors of dementia among adults with post-traumatic stress disorder: a systematic review
            protocol. <em>BMJ Open</em>. 2020;10(6):e035517. Published 2020 Jun 3. doi:10.1136/bmjopen-2019-035517</p>
    </li>
</ol></div></div></div></div></div>